Showing all 3 results
Saxagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Saxagliptin (as Hydrochloride) INN/Ph.Eur. 2.5 mg Target dose for patients with moderate/severe renal impairment or those taking strong CYP3A4 inhibitors. Saxagliptin (as Hydrochloride) INN/Ph.Eur. 5 mg Global Clinical Standard: Maximum adult daily dose for the maintenance of Type 2 Diabetes. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Diluent / Binder / Superdisintegrant (Engineered for immediate gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens).
Teneligliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Bilayer or Matrix Sustained-Release Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the highly hygroscopic Metformin component.
Active Ingredient Strength Primary Clinical Function Teneligliptin Hydrobromide Hydrate INN 20 mg Immediate-release DPP-4 inhibition for rapid post-prandial (after-meal) glucose control. Metformin Hydrochloride BP/Ph.Eur. 500 mg (Sustained-Release) Continuous 24-hour hepatic glucose suppression and peripheral insulin sensitization. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 24-hour kinetic release of Metformin) Teneligliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the active pharmaceutical ingredient across diverse tropical and high-humidity climates.
Active Ingredient Strength Primary Clinical Use Teneligliptin Hydrobromide Hydrate INN 20 mg Standard Global Dose: Once-daily therapy for glycemic control in Type 2 Diabetes. Excipients Microcrystalline Cellulose / Mannitol / Croscarmellose Sodium / Magnesium Stearate Diluent / Superdisintegrant (Engineered for immediate gastric dissolution and rapid absorption)
